Brown-forman Earnings Calls
| Release date | Dec 04, 2025 |
| EPS estimate | - |
| EPS actual | - |
| Revenue estimate | 1.021B |
| Revenue actual | - |
| Expected change | +/- 4.26% |
| Release date | Aug 28, 2025 |
| EPS estimate | $0.365 |
| EPS actual | $0.359 |
| EPS Surprise | -1.51% |
| Revenue estimate | 1.018B |
| Revenue actual | 924M |
| Revenue Surprise | -9.21% |
| Release date | Jun 03, 2025 |
| EPS estimate | $0.344 |
| EPS actual | $0.309 |
| EPS Surprise | -10.21% |
| Revenue estimate | 967.067M |
| Revenue actual | 894M |
| Revenue Surprise | -7.56% |
| Release date | Mar 04, 2025 |
| EPS estimate | $0.462 |
| EPS actual | $0.571 |
| EPS Surprise | 23.67% |
| Revenue estimate | 987.657M |
| Revenue actual | 1.035B |
| Revenue Surprise | 4.79% |
Last 4 Quarters for Brown-forman
Below you can see how 0HQ3.L performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Mar 04, 2025 |
| Price on release | $33.04 |
| EPS estimate | $0.462 |
| EPS actual | $0.571 |
| EPS surprise | 23.67% |
| Date | Price |
|---|---|
| Feb 26, 2025 | $32.95 |
| Feb 27, 2025 | $32.73 |
| Feb 28, 2025 | $33.25 |
| Mar 03, 2025 | $33.33 |
| Mar 04, 2025 | $33.04 |
| Mar 05, 2025 | $35.48 |
| Mar 06, 2025 | $34.89 |
| Mar 07, 2025 | $37.01 |
| Mar 10, 2025 | $37.91 |
| 4 days before | 0.273% |
| 4 days after | 14.74% |
| On release day | 7.38% |
| Change in period | 15.05% |
| Release date | Jun 03, 2025 |
| Price on release | $33.33 |
| EPS estimate | $0.344 |
| EPS actual | $0.309 |
| EPS surprise | -10.21% |
| Date | Price |
|---|---|
| May 28, 2025 | $34.35 |
| May 29, 2025 | $34.28 |
| May 30, 2025 | $33.84 |
| Jun 02, 2025 | $32.92 |
| Jun 03, 2025 | $33.33 |
| Jun 04, 2025 | $33.44 |
| Jun 05, 2025 | $27.52 |
| Jun 06, 2025 | $27.97 |
| Jun 09, 2025 | $27.23 |
| 4 days before | -2.96% |
| 4 days after | -18.30% |
| On release day | 0.330% |
| Change in period | -20.72% |
| Release date | Aug 28, 2025 |
| Price on release | $28.75 |
| EPS estimate | $0.365 |
| EPS actual | $0.359 |
| EPS surprise | -1.51% |
| Date | Price |
|---|---|
| Aug 22, 2025 | $31.08 |
| Aug 25, 2025 | $30.90 |
| Aug 26, 2025 | $29.70 |
| Aug 27, 2025 | $29.94 |
| Aug 28, 2025 | $28.75 |
| Aug 29, 2025 | $29.58 |
| Sep 01, 2025 | $29.54 |
| Sep 02, 2025 | $29.24 |
| Sep 03, 2025 | $28.60 |
| 4 days before | -7.50% |
| 4 days after | -0.522% |
| On release day | 2.75% |
| Change in period | -7.98% |
| Release date | Dec 04, 2025 |
| Price on release | - |
| EPS estimate | - |
| EPS actual | - |
| Date | Price |
|---|---|
| Nov 11, 2025 | $27.96 |
| Nov 12, 2025 | $27.84 |
| Nov 13, 2025 | $28.20 |
| Nov 14, 2025 | $27.80 |
| Nov 17, 2025 | $27.76 |
Brown-forman Earnings Call Transcript Summary of Q3 2025
Key investor takeaways: Brown-Forman returned to year-to-date organic net sales growth (+2% after adjustments) and organic operating income growth (+5% YTD), driven by strength in Woodford Reserve (organic net sales +10%) and sequential improvement in Jack Daniel's Tennessee Whiskey (+2% YTD). RTDs (Jack & Coke, New Mix) and emerging markets (collectively +8%) were material growth contributors. Management reaffirmed full‑year fiscal 2025 guidance: organic net sales growth of 2%–4% (guiding nearer the low end) and organic operating income growth of 2%–4% (guiding to the upper end). They are executing route‑to‑consumer changes (own distribution in Japan, Italy launch May 1, 2025; new California distributor Reyes Beverage Group effective May 1), and announced organizational actions — a ~12% global workforce reduction and closure of the Louisville Cooperage — expected to incur ~$60–70M of charges and deliver ~$70–80M of annualized savings (with >$30M in asset proceeds). Tariff risk (EU, Mexico, Canada) remains a significant near‑term uncertainty; management has mitigation plans and says potential tariff impacts are included in FY25 guidance. Financial highlights: reported gross margin contracted ~150 bps to 59.4% (sequential improvement), reported EPS down 4% to $1.53, Duckhorn investment sale generated $350M cash and a $78M gain, capex guidance of $180–190M, and updated effective tax rate guidance to ~20%–22%. Distributor inventories remain at the low end of normal ranges; management expects shipments and depletions to largely come back into line by year end.
Sign In
Buy 0HQ3